From: Effects of the diabetes linked TCF7L2polymorphism in a representative older population
Diabetes | Diabetes and impaired fasting glucose | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Genotype | n | % | Age- and sex-adjusted OR | 95% CI | p value | n | % | Age- and sex-adjusted OR | 95%CI | p value | |
Two or more metabolic syndrome features | CC | 33 | 73.3 | 56 | 66.7 | ||||||
CT/TT | 41 | 58.6 | 0.37 | 0.15–0.92 | 0.033 | 78 | 55.7 | 0.55 | 0.30–0.99 | 0.047 | |
High blood pressure or anti-hypertension drugs | CC | 37 | 78.7 | 64 | 74.4 | ||||||
CT/TT | 47 | 61.8 | 0.37 | 0.16–0.90 | 0.028 | 101 | 67.8 | 0.65 | 0.35–1.20 | 0.170 | |
Abdominal obesity | CC | 25 | 54.4 | 44 | 51.8 | ||||||
CT/TT | 35 | 49.3 | 0.53 | 0.20–1.35 | 0.180 | 67 | 46.9 | 0.67 | 0.36–1.22 | 0.188 | |
High triglycerides | CC | 20 | 41.7 | 39 | 44.8 | ||||||
CT/TT | 25 | 32.5 | 0.68 | 0.32–1.43 | 0.307 | 49 | 32.2 | 0.58 | 0.33–0.99 | 0.047 | |
Low HDL levels | CC | 17 | 35.4 | 31 | 35.6 | ||||||
CT/TT | 26 | 33.8 | 0.83 | 0.37–1.86 | 0.651 | 44 | 29 | 0.67 | 0.37–1.21 | 0.185 | |
Myocardial infarction | CC | 7 | 14.6 | 8 | 9.2 | ||||||
CT/TT | 2 | 2.6 | 0.16 | 0.03–0.84 | 0.030 | 4 | 2.6 | 0.27 | 0.08–0.92 | 0.037 | |
Poor renal function (24-hour creatinine clearance) | CC | 12 | 26.1 | 31 | 36.9 | ||||||
CT/TT | 32 | 47.1 | 3.15 | 1.27–7.81 | 0.013 | 69 | 49.3 | 1.74 | 0.96–3.17 | 0.066 | |
Retinopathy reported | CC | 1 | 2.0 | 1 | 1.1 | ||||||
CT/TT | 11 | 14.1 | 7.15 | 0.87–58.51 | 0.067 | 11 | 7.2 | 6.13 | 0.77–48.86 | 0.087 | |
Dementia (physician diagnosed) | CC | 1 | 2.0 | 1 | 1.1 | ||||||
CT/TT | 8 | 10.3 | 10.67 | 1.00–113.70 | 0.050 | 13 | 8.5 | 11.62 | 1.38–97.57 | 0.024 |